Complete headline results for Commercial Deal, when?, page-286

The complex nature of timing the release of results and specifically why Covid result is not yet available could always be because BIT225 has a broad spectrum of applications.
We have been advised of HIV ( art supplementary),Covid (mouse model so far), further Corona viruses, Zika etc and as a General Antiviral.
Has there yet been an antiviral or any other drug type with this potential?
Then how do they value the package?
It seems obvious that a single BP buyer would be easiest.
Is there any fear of missing out factor?
The MM comment has some reason for validity plus the “No CR” one.